|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the OPTR DEF 14A filed Apr 9, 2009. Compensation CommitteeThe Compensation Committee consists of Drs. Joseph Chang and Schreiber and, since February 2009, Dr. Grebow. The functions of this committee include, among other things:
· evaluating and recommending to our Board of Directors the compensation and other terms of employment of our executive officers and reviewing and approving corporate performance goals and objectives relevant to such compensation;
· evaluating and recommending to our Board of Directors the type and amount of compensation to be paid or awarded to board members;
8
· evaluating and recommending to our Board of Directors the equity incentive plans, compensation plans and similar programs advisable for us, as well as modification or termination of existing plans and programs;
· administering our equity incentive plans;
· establishing policies with respect to equity compensation arrangements;
· reviewing and approving the terms of any employment agreements, severance arrangements, change-in-control protections and any other compensatory arrangements for our executive officers; and
· reviewing and evaluating, at least annually, the performance of the Compensation Committee.
The Compensation Committee has adopted a written charter that is available on the Company’s website at www.optimerpharma.com and met five times during the fiscal year ended December 31, 2008. This excerpt taken from the OPTR DEF 14A filed Apr 18, 2008. Compensation CommitteeThe Compensation Committee consists of Drs. Joseph Chang and Schreiber. The functions of this committee include, among other things:
· evaluating and recommending to our Board of Directors the compensation and other terms of employment of our executive officers and reviewing and approving corporate performance goals and objectives relevant to such compensation;
· evaluating and recommending to our Board of Directors the type and amount of compensation to be paid or awarded to board members;
9
· evaluating and recommending to our Board of Directors the equity incentive plans, compensation plans and similar programs advisable for us, as well as modification or termination of existing plans and programs;
· administering our equity incentive plans;
· establishing policies with respect to equity compensation arrangements;
· reviewing and approving the terms of any employment agreements, severance arrangements, change-in-control protections and any other compensatory arrangements for our executive officers; and
· reviewing and evaluating, at least annually, the performance of the Compensation Committee.
The Compensation Committee has adopted a written charter that is available to stockholders on the Company’s website at www.optimerpharma.com and met five times during the fiscal year ended December 31, 2007.
| EXCERPTS ON THIS PAGE:
|
| |||||||
